This article is more than 5 years old. Information may no longer be current.

Lupin recalls 43,860 moxifloxacin bottles

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Lupin Pharmaceuticals has voluntarily recalled 43,860 bottles of moxifloxacin ophthalmic solution due to failed impurities or degradation specifications, according to an FDA Enforcement Report.

Used to treat bacterial conjunctivitis, the antibiotic was distributed in the United States by five wholesalers, six drug chains, four mail-order pharmacies and one mail-order pharmacy/supermarket, the FDA report said.

The class III recall, in which use of the product is not likely to cause adverse health consequences, affects lot numbers H705562, H705563 and H800616.